{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T06:14:52Z","timestamp":1778739292703,"version":"3.51.4"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"vor","delay-in-days":252,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"NIHR","doi-asserted-by":"publisher","award":["NIHR200908"],"award-info":[{"award-number":["NIHR200908"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","award":["2305-IAI-PDR-Flu-Vac"],"award-info":[{"award-number":["2305-IAI-PDR-Flu-Vac"]}],"id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000761","name":"Imperial College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000761","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018336","name":"National Institute for Health Research Health Protection Research Unit","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009660","name":"London School of Hygiene and Tropical Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009660","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000276","name":"Department of Health and Social Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000276","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.vaccine.2026.128455","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T10:28:49Z","timestamp":1773397729000},"page":"128455","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"S2","title":["The potential global health impact and net monetary benefit of programmatic use of improved influenza vaccines: a mathematical modelling study"],"prefix":"10.1016","volume":"60","author":[{"given":"Lucy","family":"Goodfellow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Soble","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Malvolti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Lambach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Jit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosalind M.","family":"Eggo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon R.","family":"Procter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.128455_bb0005","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0140-6736(17)33293-2","article-title":"Estimates of global seasonal influenza-associated respiratory mortality: a modelling study","volume":"391","author":"Iuliano","year":"2018","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.vaccine.2026.128455_bb0010","series-title":"Vaccines against influenza: WHO position paper \u2013 May 2022","author":"World Health Organization","year":"2022"},{"key":"10.1016\/j.vaccine.2026.128455_bb0015","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12916-023-02830-w","article-title":"Potential health and economic impact of paediatric vaccination using next-generation influenza vaccines in Kenya: a modelling study","volume":"21","author":"Waterlow","year":"2023","journal-title":"BMC Med"},{"key":"10.1016\/j.vaccine.2026.128455_bb0020","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2024-015837","article-title":"Health impact and cost-effectiveness of vaccination using potential next-generation influenza vaccines in Thailand: a modelling study","volume":"9","author":"Procter","year":"2024","journal-title":"BMJ Glob Health"},{"key":"10.1016\/j.vaccine.2026.128455_bb0025","doi-asserted-by":"crossref","first-page":"6017","DOI":"10.1016\/j.vaccine.2023.08.031","article-title":"The potential cost-effectiveness of next generation influenza vaccines in England and Wales: a modelling analysis","volume":"41","author":"Waterlow","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128455_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004655","article-title":"The potential global health impact and cost-effectiveness of next-generation influenza vaccines: a modelling analysis","volume":"22","author":"Goodfellow","year":"2025","journal-title":"PLOS Med"},{"key":"10.1016\/j.vaccine.2026.128455_bb0035","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/vaccines12010004","article-title":"The global demand and supply balance of the human papillomavirus vaccine: implications for the global strategy for the elimination of cervical cancer","volume":"12","author":"Malvolti","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2026.128455_bb0040","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1080\/21645515.2018.1553593","article-title":"Experiences with rotavirus vaccines: can we improve rotavirus vaccine impact in developing countries?","volume":"15","author":"Steele","year":"2019","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.vaccine.2026.128455_bb0045","doi-asserted-by":"crossref","first-page":"e1485","DOI":"10.1016\/S2214-109X(24)00232-8","article-title":"Re-evaluating the impact and cost-effectiveness of pneumococcal conjugate vaccine introduction in 112 low-income and middle-income countries in children younger than 5\u00a0years: a modelling study","volume":"12","author":"Chen","year":"2024","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2026.128455_bb0050","unstructured":"World Health Organization. Full Value of improved Influenza Vaccine Assessment (FVIVA) n.d. https:\/\/www.who.int\/teams\/immunization-vaccines-and-biologicals\/immunization-analysis-and-insights\/vaccine-impact-value\/full-value-of-improved-influenza-vaccine-assessment-(fviva) (accessed August 8, 2025)."},{"key":"10.1016\/j.vaccine.2026.128455_bb0055","doi-asserted-by":"crossref","first-page":"7044","DOI":"10.1016\/j.vaccine.2023.10.047","article-title":"The need and ongoing efforts to understand the full value of improved influenza vaccines","volume":"41","author":"Bresee","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128455_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.128166","article-title":"Evaluating the broader impact of improved influenza vaccines: a full value of vaccine assessment approach","volume":"60","author":"Soble","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128455_bb0065","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ijid.2023.02.002","article-title":"The global region-specific epidemiologic characteristics of influenza: World Health Organization FluNet data from 1996 to 2021","volume":"129","author":"Chen","year":"2023","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128455_bb0070","unstructured":"World Health Organization. FluNet. Glob Influenza Programme n.d. https:\/\/www.who.int\/tools\/flunet (accessed August 22, 2024)."},{"key":"10.1016\/j.vaccine.2026.128455_bb0075","series-title":"World Population Prospects 2022","author":"United Nations","year":"2022"},{"key":"10.1016\/j.vaccine.2026.128455_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1009098","article-title":"Projecting contact matrices in 177 geographical regions: an update and comparison with empirical data for the COVID-19 era","volume":"17","author":"Prem","year":"2021","journal-title":"PLOS Comput Biol"},{"key":"10.1016\/j.vaccine.2026.128455_bb0085","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/aje\/kwm375","article-title":"Time lines of infection and disease in human influenza: a review of volunteer challenge studies","volume":"167","author":"Carrat","year":"2008","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2026.128455_bb0090","doi-asserted-by":"crossref","first-page":"04003","DOI":"10.7189\/jogh.13.04003","article-title":"Global and national influenza-associated hospitalisation rates: estimates for 40 countries and administrative regions","volume":"13","author":"Paget","year":"2023","journal-title":"J Glob Health"},{"key":"10.1016\/j.vaccine.2026.128455_bb0095","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jinf.2013.11.013","article-title":"The burden of influenza in England by age and clinical risk group: a statistical analysis to inform vaccine policy","volume":"68","author":"Cromer","year":"2014","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2026.128455_bb0100","unstructured":"Institute for Health Metrics and Evaluation (IHME). Global Burden of Disease Study 2016 (GBD 2016) Disability Weights n.d."},{"key":"10.1016\/j.vaccine.2026.128455_bb0105","doi-asserted-by":"crossref","first-page":"e833","DOI":"10.1016\/S2214-109X(23)00162-6","article-title":"Determining the efficiency path to universal health coverage: cost-effectiveness thresholds for 174 countries based on growth in life expectancy and health expenditures","volume":"11","author":"Pichon-Riviere","year":"2023","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2026.128455_bb0110","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s40273-020-00930-6","article-title":"Producing standardized country-level immunization delivery unit cost estimates","volume":"38","author":"Portnoy","year":"2020","journal-title":"PharmacoEconomics"},{"key":"10.1016\/j.vaccine.2026.128455_bb0115","series-title":"Revising global indicative wastage rates: a WHO initiative for better planning and forecasting of vaccine supply needs","author":"World Health Organization","year":"2019"},{"key":"10.1016\/j.vaccine.2026.128455_bb0120","series-title":"WHO guide for standardization of economic evaluations of immunization programmes","author":"World Health Organization","year":"2019"},{"key":"10.1016\/j.vaccine.2026.128455_bb0130","series-title":"Global Market Study, Seasonal Influenza Vaccine","author":"World Health Organization","year":"2024"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2600263X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2600263X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T05:48:27Z","timestamp":1778737707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2600263X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":25,"alternative-id":["S0264410X2600263X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128455","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The potential global health impact and net monetary benefit of programmatic use of improved influenza vaccines: a mathematical modelling study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128455","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128455"}}